Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript May 6, 2024
Travere Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.7639 EPS, expectations were $-0.98. Travere Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day and welcome to the Travere Therapeutics First Quarter 2024 Financial Results and Corporate Update Conference Call. Today’s call is...
